TABLE 90-17
| Table 90-17. Phase ll Chemotherapy Results in Salivary Gland Cancers | |||||
No. of Author |
Patients |
Histology |
Agent(s) |
Objective Response rate (%) |
Meduan Survival (mo)** |
| Tannock673 | 17 | AC | Mult | 29 | 21 |
| Alberts7 | 5 | Mult | CDP | 100 | 8 |
| Schramm591 | 10 | AC | P | 70 | 7-18 |
| Posner540 | 13 | Mult | CD | 38 | 8 |
| 3 | Mucd | PBM | 66 | 6 | |
| Suen665 | 14 | AC | P | 64 | — |
| Sessions599 | 14 | AC | P | 50 | — |
| Creagan140 | 34 | Mult | P-based | 38 | 15 |
| Eisenberger200 | 4 | Mult | CDP | 100 | 11+ |
| Dreyfuss193 | 13 | Mult | CDP | 46 | — |
| Triozzi694 | 21 | AC | COF | 25 | — |
| Venook707 | 17 | Mult | 35 | 15 | |
| Licitra422 | 23 | Mult | P | 17 | — |
| Dimery183 | 16 | Mult | FACP | 50 | 18 |
| AC = adenoid cystic carcinoma; Mucd = mucoepidermoid carcinoma; Mult = multiple; D = doxorubicin; B = bleomycin; C = cyclophosphamide; F = 5-fluorouracil; M = methotrexate; O = vincristine; P = cisplatin; V = vinblastine; — = no data | |||||
| *Excluding isolated case reports | |||||
| **From diagnosis | |||||